Resumen
In the USA, cardiovascular disease is the leading cause of morbidity and mortality, accounting for approximately 40% of all deaths. Myocardial infarction or its sequelae is the primary cause of cardiovascular disease death. Despite advances in novel therapeutic strategies over the past 30 years, heart failure morbidity and mortality remain high for the post-myocardial infarction patient. Extracellular matrix remodeling and its role in heart failure are explored in this chapter: the key players involved, current therapeutic options and future trends are discussed.
| Idioma original | English (US) |
|---|---|
| Título de la publicación alojada | Pathology and Therapies |
| Editorial | Elsevier Ltd |
| Páginas | 41-60 |
| Número de páginas | 20 |
| Volumen | 1 |
| ISBN (versión impresa) | 9780857096586 |
| DOI | |
| Estado | Published - feb 2014 |
ASJC Scopus subject areas
- General Dentistry
- General Medicine
Huella
Profundice en los temas de investigación de 'Modifying matrix remodeling to prevent heart failure'. En conjunto forman una huella única.Citar esto
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS